Norges Bank Takes $468.12 Million Position in GE HealthCare Technologies Inc. $GEHC

Norges Bank purchased a new position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 6,319,974 shares of the company’s stock, valued at approximately $468,120,000. Norges Bank owned about 1.38% of GE HealthCare Technologies at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Allianz SE grew its holdings in GE HealthCare Technologies by 165.2% during the 2nd quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the period. Gladwyn Financial Advisors Inc. acquired a new position in shares of GE HealthCare Technologies in the 2nd quarter valued at $34,000. Game Plan Financial Advisors LLC boosted its position in shares of GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock worth $37,000 after purchasing an additional 375 shares during the last quarter. Zions Bancorporation National Association UT acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $42,000. Finally, HFM Investment Advisors LLC acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $60,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $79.99 on Friday. The company has a fifty day moving average price of $75.08 and a 200 day moving average price of $74.16. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The firm has a market cap of $36.43 billion, a PE ratio of 16.53, a PEG ratio of 3.34 and a beta of 1.13. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, October 29th. The company reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The company had revenue of $5.14 billion for the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The company’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the company posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Stockholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.89%.

Analysts Set New Price Targets

GEHC has been the topic of several analyst reports. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Monday, November 17th. Wells Fargo & Company lowered their price target on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating for the company in a research note on Thursday, October 30th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, September 20th. BTIG Research restated a “buy” rating and set a $87.00 price objective on shares of GE HealthCare Technologies in a report on Friday, November 21st. Finally, Morgan Stanley upped their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the company an “equal weight” rating in a research note on Thursday, October 30th. Six analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $86.45.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.